Vision 2008; 14:20-28
Received 18 November 2007 | Accepted 6 November 2007 | Published 9 January 2008
A naturally-occurring mutation in Cacna1f in a rat model of congenital stationary night blindness
Wang,2 Jie Zhou,2 Qun Guo,1 Na Liu,2
Ding,1 Li Li,1 Xinping Liu,2 Jing An,1
Yan,1 Libo Yao,2 Zuoming
(The first two authors contributed equally to this publication)
Department of 1Clinical Aerospace Medicine and 2Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China; 3Department of Ophthalmology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China
Correspondence to: Zuoming Zhang, Department of Clinical Aerospace Medicine, Fourth Military Medical University, Xian, China; Phone: +862984774817; FAX: +862984774817; email: firstname.lastname@example.org
Purpose: To identify the gene mutation responsible for a previously described rat model of X-linked congenital stationary night blindness (CSNB).
Methods: Rat orthologous genes for Nyx and Cacna1f were isolated from retina through rapid amplification the cDNA ends (RACE) and examined for mutations. Electroretinograms were used to identify affected animals.
Results: The rat Nyx cDNA spans 1,971 nucleotides and encodes a protein of 476 amino acids (GenBank: DQ393414). The rat Cacna1f cDNA spans 6,076 nucleotides and encodes a protein of 1,980 amino acids (GenBank: DQ393415). A c.2941C>T (p.R981Stop) mutation in Cacna1f was found in affected rats. Immunochemistry study showed labeling for rod bipolar and horizontal cells were reduced in affect retinas. For affected rats, b-wave and oscillatory potentials of scotopic ERG were absent, and b-wave of photopic ERG was clear but obviously reduced.
Conclusions: The Cacna1f mutation identified in the rat model of CSNB was predicted to lead to a protein product that is shortened by 999 amino acids, indicating that this is a model for the incomplete subtype of human X-linked CSNB (CSNB2). This rat model will be useful for defining the pathophysiological properties of this human disorder.
Congenital stationary night blindness (CSNB) encompasses a group of inherited, nonprogressive retinal disorders that primarily affect night vision  and can be transmitted in autosomal recessive, autosomal dominant or X-linked modes [2-7]. The X-linked form of CSNB is frequently associated with myopia, nystagmus, decreased visual acuity, and occasionally strabismus [8-10]. Based on functional and clinical information, Miyake et al.  divided X-linked CSNB into two types: complete (CSNB1) and incomplete (CSNB2). CSNB1 is characterized by normal to mildly subnormal cone function and the complete absence of rod function. It is caused by mutations in the NYX gene, encoding a glycosylphosphatidylinositol (GPI)-anchored extracellular protein [12,13]. CSNB2 patients retain measurable rod function with significant impairment of cone function, yet have mutations in the Cacna1f gene, which encodes the α1F subunit of an L-type calcium channel [14,15]. Recently, mutations in GRM6, coding for the metabotropic glutamate receptor mGluR6 [16,17], and CABP4, encoding a calcium binding protein , have been identified as the cause of autosomal recessive CSNB (arCSNB) leading to phenotypes similar to CSNB1 and CSNB2, respectively.
We recently reported a naturally occurring rat model of X-linked CSNB . This model was originally identified by electroretinogram (ERG) recordings obtained from a single outbred Sprague Dawley rat, and the trait has since been inbred for more than 16 generations. The ERGs obtained from the original mutant showed a marked loss of the rod b-wave with relatively normal cone ERGs, and were interpreted to resemble most closely the human CSNB1 phenotype. During the inbreeding process, however, it became clear that the cone response of mutant rats was also compromised such that the overall phenotype more closely resembled the CSNB2 phenotype. In the present study, we isolated the rat orthologous genes for both Nyx and Cacna1f and examined these for mutations in affected rats. As will be described, our results indicate that this rat model of CSNB is caused by a Cacna1f mutation.
Affected and control rats were obtained from the 14th inbred generation derived from the originally identified mutant male . Since the defect is inherited as an X-linked trait, the mutant line has been maintained by mating affected males to control females and then mating carrier females to affected males. All procedures involving the animals were approved by Animal Care and Use Committee of the Fourth Military Medical University and were in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
ERG recordings were used to study the phenotype of ten affected and ten control male rats, that were 10 weeks of age. ERGs were recorded using procedures described previously . After 10 h dark adaptation, rats were anesthetized intraperitoneally with ketamine (70 mg/kg, Sigma, Saint Louis, MO) and xylazine (10 mg/kg, Sigma). The pupils were dilated with 0.5% tropicamide, and animals were secured to a platform with a heating pad to maintain the body temperature. ERGs were recorded from the corneal surface using a silver-chloride electrode loop that made contact through a layer of 1% methylcellulose. Stainless steel needle electrodes placed in the cheek served as reference leads while those placed in the tail acted as ground leads. ERGs were recorded by a commercial system (RETIport; Roland Consult GmbH, Brandenburg, Germany) using a band pass of 0.5 to 1000 Hz. Strobe stimulus flashes were delivered in a Ganzfeld, and neutral density filters were used to control stimulus intensity.
A dark-adapted intensity series was recorded first, using a stimulus range of -2.5 to 0.5 log cd s mm-2. Interstimulus intervals increased from 15 s at the lower flash intensities, to 2 min at the highest flash levels. A steady adapting field (1.3 log cd mm-2) was then presented within the Ganzfeld. After a 10-minute period of light adaptation, cone ERGs were elicited by flash stimuli superimposed against the adapting field. Cone ERGs were recorded in response to stimuli ranging from -2.5 to 0.5 log cd s mm-2. In each case, the responses to 25 consecutive flashes presented at 2.1 Hz were averaged.
Isolation of the rattus norvegicus Nyx and Cacna1f full-length cDNA
Smart Race technology (Clontech, Mountain View, CA) was used to amplify the full-length cDNA of Nyx and Cacna1f from the rat. Total RNAs were isolated from retinas of affected and control rats with Trizol reagent (Invitrogen, Frederick, MD) according to manufacturer's protocol. Primers were designed from predicted rat Nyx sequence (GenBank: NM_001100967) and available Cacna1f sequence (GenBank: NM_053701) in Table 1. The PCR products were subcloned into the pMD-18T vector (Takara, Dalian, China) and transformed into E.coli, and sequenced.
The open reading frame (ORF) and translated amino acid sequences were predicted by the National Center for Biotechnology Information's (NCBI) ORF Finder and DNAStar 2.0 program. The nucleotide and amino acid sequences were aligned in NCBI's Blast program to search for sequence matches. The chromosomal location and extron-intron structure were analyzed in the NCBI's Genomic Biology. The sequences to be analyzed were retrieved from GenBank by NCBI's Entrez system. Multiple alignments were performed with Clustal X (1.8) program. Motif searches were carried out with ExPASy and Smart program.
To identify whether a mutation in Nyx or Cacna1f gene was present in the CSNB-like rat, we designed primers to amplify fragments encompassing the full-length cDNA from both control and affected rat (Table 2). The PCR products were subcloned into TA vectors (pMD-18T, Takara) and sequenced as described in the previous section.
After 10-week old control and affected rats were killed by CO2 (5-10 min, in a sealed chamber), the eyes were enucleated, dissected along the ora serrata, and posterior eyecups were fixed in 4% paraformaldehyde at 4 °C for overnight. The eyecups were then rinsed in phosphate buffer (PB), dehydrated through a graded series of ethanol washes, and embedded in paraffin. A microtome was used to cut 5 μm thick sections, which were mounted onto slides and stained with hematoxylin and eosin for anatomy analysis.
Sections were rehydrated, and 3% H2O2 in 40% methanol was used to block the endogenous peroxidase. After sections were incubated in blocking solution (10% goat serum, Boster) for 30 min, solutions were replaced and sections were incubated with primary antibody diluted in blocking solution at 4 °C for overnight. Primary antibodies used were a 1:5000 of anti-protein kinase Cα (PKC, Sigma) and a 1:3000 dilution of anti-calbindin D-28K (Chemicon, Southampton, UK). After washing with PB, sections were incubated in a 1:1000 dilution of biotin-conjugated secondary antibody (Boster, Wuhan, China) for 1 h. After a wash in PB, sections were incubated in an avidin-biotin peroxidase complex (Boster) for 30 min. Sections were rinsed in PB and immunoreaction was visualized with a diaminobenzidine-nickel solution (Boster) as the chromogen. The reaction in PB, before slides were coverslipped and images were captured digitally on light microscopy.
Figure 1A presents ERGs recorded from representative control (left) and mutant (right) animals under dark-adapted conditions. Under dark-adapted conditions, ERGs of mutant rats lacked distinct b-waves or oscillatory potentials throughout the range of stimulus intensities. In response to high stimulus intensities, mutant rats generated a clear a-wave. In comparison to control responses, a-waves of mutant rats were significantly reduced in amplitude. Figure 1B,C show intensity-response functions for dark-adapted a- and b-waves of ten control and ten affected rats.
Figure 2A presents representative ERGs recorded under light-adapted conditions. In comparison to control responses, light-adapted ERGs of mutant rats were significantly smaller in amplitude and delayed in peak time. Figure 2B,C show intensity-response functions for the cone ERGs.
Isolation of rat Nyx and Cacna1f cDNA
Full-length rat Nyx cDNA spans 1,971 nucleotides (GenBank: DQ393414). Compared with the computational predicted one (GenBank: NM_001100967), this sequence has complete 5' and 3' UTR. When aligned with the rat genome, it was predicted to locate in Xq12 and contain 3 exons. The ORF was confined to exon 2 and 3 as in human [12,13], mouse [21,22], chic , and zebrafish  genes, and encodes a protein of 476 amino acids with a predicted molecular weight of 52.5 kDa. The nucleotide sequence is 86% and 93% identical to human (GenBank: NM_022567) and mouse (GenBank: NM_173415) sequences, respectively. The translated amino acid sequence is 84% and 95% identical to human (GenBank: NP_072089) and mouse (GenBank: NP_775591) sequences, respectively (Figure 3). Computational protein motif analysis of rat Nyx predicted a characteristic domain structure: the N-terminal putative signal sequence, the core segment consists of 11 leucine-rich regions (LRRs) flanked by two cysteine-rich LRRs (LRRNT and LRRCT). Unlike human, the C-terminal GPI membrane anchor was not predicted in rat sequence. Only a potential cleavage site was found at C-terminal. Identity was much higher in the LRR core segment than in the signal sequence and C terminal among the species. Recent work has suggested both human and mouse nyctalopin are membrane-bound extracellular proteins with function conserved , and orthologous nyctalopin proteins may have different mechanisms of cell membrane attachment .
Full-length of rat Cacna1f cDNA spans 6,076 nucleotides (GenBank: DQ393415) and has complete 3'-UTR compared with available one (GenBank: NM_053701). When aligned with the rat genome, it was predicted to locate in Xq13 and contain 49 exons. The ORF was confined to all of the exons and encodes a protein of 1980 amino acids with a predicted molecular weight of 220.0 kDa. The rat Cacna1f shares 88% and 95% identity with human (Genbank: NM_053701) and mouse (GenBank: NM_019582) sequences, respectively. The translated amino acids shares 91% and 97% with human (GenBank: NP_005174) and mouse (Genbank: NP_062528) sequences, respectively (Figure 4). Computational protein motif analysis showed four homologous domains of ion transport protein (Ion_trans), each containing six transmembrane alpha helices. The transmembrane segments were best conserved among species, and the most disparate regions were C terminal and cytoplasmic loop between domains 2 and 3 .
To identify the mutation responsible for CSNB rats, we amplified fragments encompassing Nyx or Cacna1f from cDNAs isolated from the retinas of control and mutant rats, which were identified by ERG analysis. Sequence analysis revealed a point mutation of C to T at position 2941, which changes codon 981 from arginine (CGA) to a stop codon (TGA). This R981Stop point mutation was predicted to lead to a version of protein shortened by a total of 999 amino acids, and missing the C-terminal and, in particular, part of the third and all of the fourth ion transport domains.
To confirm that R981Stop was casually associated with the phenotype, we analyzed 24 rats obtained in our breeding pedigree (Figure 5). After ERGs were used to determine the phenotype, the mutant position was amplified from each animal's retinal cDNA. All seven affected rats were found to carry the c.2941C>T mutation in the retinal cDNAs, while no rat with a normal ERG carried this mutation.
Histology and immunochemistry
Histology showed that retinal structures were similar in both control and affected rats (Figure 6A,B). Labeling of control retinas with PKCα showed dendrites of bipolar cells terminated in the OPL (Figure 6C), in agreement with previous reports [28-31], whereas labeling with PKCα in affected retina was much reduced (Figure 6D). Labeling of control rat for horizontal cells with calbindin showed staining of bodies and processes in OPL (Figure 6E), in contrast, labeling for horizontal cells in affected retinas were rare (Figure 6F). In affected retinas, no extension to outer nuclear layer for dendrites of rod bipolar cells and horizontal cells were observed.
This study found that the rat mutant identified by ERG recordings  carried a mutation in the Cacna1f gene, while Nyx is normal. As a consequence, the rat model provides a new model for CSNB2, which also involves Cacna1f mutations. The protein encoded by Cacna1f is the α1F subunit of voltage-gated L-type calcium channels, which appear to be expressed only in the retina . Immunohistochemical analysis has localized this subunit to the ribbon active zones in rod photoreceptor terminals . The visual signal generated by rod and cone photoreceptors in response to light is transmitted to second order neurons through glutamate released at ribbon synapses located in the rod and cone terminals . Thus, a defect in α1F would be expected to severely diminish post-receptoral transmission of the visual signal, which is clearly seen in all patients with CSNB2 and in the available animal models.
There are two mouse models for CSNB2. Mansergh et al  described the phenotype of a knock-out model (Cacna1f-/-), while Chang et al  detailed a naturally-occurring mutant (nob2) identified, like the rat model under consideration, through fortuitous ERG studies. The rat phenotype appears to be an intermediate between these two mouse models. Under dark-adapted conditions, ERG b-waves and oscillatory potentials are essentially absent (Figure 1). This resembles the phenotype of Cacna1f-/- mice  but not of the nob2 mouse . Under light-adapted conditions, affected rats generated clear cone ERGs of reduced amplitude (Figure 2). This phenotypic feature resembles more closely the results obtained in nob2 mice  than of Cacna1f-/- mice . Immunochemistry showed that labeling for both rod bipolar cells and horizontal cells in affected retinas were reduced, especially for horizontal cells. This indicates that presence and activity of voltage-gated L-type calcium channels are essential for development of second-order neurons, such as bipolar and horizontal cells. Contrary to observations made in Cacna1f mutant mouse models, neither rod bipolar nor horizontal cells dendrites were observed to extend beyond the OPL in the rat. Given the range of phenotype seen in these mouse models and in human patients with Cacna1f mutations [14,15], the Cacna1f rat model will provide an additional animal model with which to understand the relationship between Cacna1f mutations and retinal phenotypes.
We thank Dr. Neal S. Peachey (Cole Eye Institute, Cleveland Clinic) for improving the article and good suggestions. This work was supported by grant 30571999 and 30371517 from the National Natural Science Foundation of China; and grant 2004009 from FMMU Sustenation Fund for Doctor Degree.
1. Carr RE. Congenital stationary nightblindness. Trans Am Ophthalmol Soc 1974; 72:448-87.
2. Merin S, Rowe H, Auerbach E, Landau J. Syndrome of congenital high myopia with nyctalopia. Report of findings in 25 families. Am J Ophthalmol 1970; 70:541-7.
3. Der Kaloustian VM, Baghdassarian SA. The autosomal recessive variety of congenital stationary night-blindness with myopia. J Med Genet 1972; 9:67-9.
4. Weleber RG, Tongue AC. Congenital stationary night blindness presenting as Leber's congenital amaurosis. Arch Ophthalmol 1987; 105:360-5.
5. Abramowicz MJ, Ribai P, Cordonnier M. Congenital stationary night blindness: report of an autosomal recessive family and linkage analysis. Am J Med Genet A 2005; 132:76-9.
6. Francois J, Verriest G, De Rouck A. A new pedigree of idiopathic congenital night-blindness: transmitted as a dominant hereditary trait. Am J Ophthal, 1965; 59: 621-625.
7. Khouri G, Mets MB, Smith VC, Wendell M, Pass AS. X-linked congenital stationary night blindness. Review and report of a family with hyperopia. Arch Ophthalmol 1988; 106:1417-22.
8. Francois J, De Rouck A. Sex-linked myopic chorioretinal heredodegeneration. Am J Ophthalmol 1965; 60:670-8.
9. Hittner HM, Borda RP, Justice J Jr. X-linked recessive congenital stationary night blindness, myopia, and tilted discs. J Pediatr Ophthalmol Strabismus 1981 Jan-Feb; 18:15-20.
10. Jay M. The Eisdell pedigree. Congenital stationary night-blindness with myopia. Trans Ophthalmol Soc U K 1983; 103 (Pt 2):221-6.
11. Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T. Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol 1986; 104:1013-20.
12. Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, Bergen AA, Prinsen CF, Polomeno RC, Gal A, Drack AV, Musarella MA, Jacobson SG, Young RS, Weleber RG. Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 2000; 26:319-23.
13. Pusch CM, Zeitz C, Brandau O, Pesch K, Achatz H, Feil S, Scharfe C, Maurer J, Jacobi FK, Pinckers A, Andreasson S, Hardcastle A, Wissinger B, Berger W, Meindl A. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet 2000; 26:324-7.
14. Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 1998; 19:264-7.
15. Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, Ruther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 1998; 19:260-3.
16. O'Connor E, Allen LE, Bradshaw K, Boylan J, Moore AT, Trump D. Congenital stationary night blindness associated with mutations in GRM6 encoding glutamate receptor MGluR6. Br J Ophthalmol 2006; 90:653-4.
17. Zeitz C, van Genderen M, Neidhardt J, Luhmann UF, Hoeben F, Forster U, Wycisk K, Matyas G, Hoyng CB, Riemslag F, Meire F, Cremers FP, Berger W. Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram. Invest Ophthalmol Vis Sci 2005; 46:4328-35.
18. Zeitz C, Kloeckener-Gruissem B, Forster U, Kohl S, Magyar I, Wissinger B, Matyas G, Borruat FX, Schorderet DF, Zrenner E, Munier FL, Berger W. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet 2006; 79:657-67.
19. Zhang Z, Gu Y, Li L, Long T, Guo Q, Shi L. A potential spontaneous rat model of X-linked congenital stationary night blindness. Doc Ophthalmol 2003; 107:53-7.
20. Gu YH, Zhang ZM, Long T, Li L, Hou BK, Guo Q. A naturally occurring rat model of X-linked cone dysfunction. Invest Ophthalmol Vis Sci 2003; 44:5321-6.
21. Gregg RG, Mukhopadhyay S, Candille SI, Ball SL, Pardue MT, McCall MA, Peachey NS. Identification of the gene and the mutation responsible for the mouse nob phenotype. Invest Ophthalmol Vis Sci 2003; 44:378-84.
22. Pesch K, Zeitz C, Fries JE, Munscher S, Pusch CM, Kohler K, Berger W, Wissinger B. Isolation of the mouse nyctalopin gene nyx and expression studies in mouse and rat retina. Invest Ophthalmol Vis Sci 2003; 44:2260-6.
23. Bech-Hansen NT, Cockfield J, Liu D, Logan CC. Isolation and characterization of the leucine-rich proteoglycan nyctalopin gene (cNyx) from chick. Mamm Genome 2005; 16:815-24.
24. Bahadori R, Biehlmaier O, Zeitz C, Labhart T, Makhankov YV, Forster U, Gesemann M, Berger W, Neuhauss SC. Nyctalopin is essential for synaptic transmission in the cone dominated zebrafish retina. Eur J Neurosci 2006; 24:1664-74. Erratum in: Eur J Neurosci. 2007 Mar;25(5):1618.
25. Zeitz C, Scherthan H, Freier S, Feil S, Suckow V, Schweiger S, Berger W. NYX (nyctalopin on chromosome X), the gene mutated in congenital stationary night blindness, encodes a cell surface protein. Invest Ophthalmol Vis Sci 2003; 44:4184-91.
26. O'Connor E, Eisenhaber B, Dalley J, Wang T, Missen C, Bulleid N, Bishop PN, Trump D. Species specific membrane anchoring of nyctalopin, a small leucine-rich repeat protein. Hum Mol Genet 2005; 14:1877-87.
27. Morgans CW, Gaughwin P, Maleszka R. Expression of the alpha1F calcium channel subunit by photoreceptors in the rat retina. Mol Vis 2001; 7:202-9 <http://www.molvis.org/molvis/v7/a28/>.
28. Greferath U, Grunert U, Wassle H. Rod bipolar cells in the mammalian retina show protein kinase C-like immunoreactivity. J Comp Neurol 1990; 301:433-42.
29. Haverkamp S, Wassle H. Immunocytochemical analysis of the mouse retina. J Comp Neurol 2000; 424:1-23.
30. Mansergh F, Orton NC, Vessey JP, Lalonde MR, Stell WK, Tremblay F, Barnes S, Rancourt DE, Bech-Hansen NT. Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Hum Mol Genet 2005; 14:3035-46.
31. Chang B, Heckenlively JR, Bayley PR, Brecha NC, Davisson MT, Hawes NL, Hirano AA, Hurd RE, Ikeda A, Johnson BA, McCall MA, Morgans CW, Nusinowitz S, Peachey NS, Rice DS, Vessey KA, Gregg RG. The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci 2006 Jan-Feb; 23:11-24.
32. Morgans CW, Bayley PR, Oesch NW, Ren G, Akileswaran L, Taylor WR. Photoreceptor calcium channels: insight from night blindness. Vis Neurosci 2005 Sep-Oct; 22:561-8.
33. Morgans CW. Neurotransmitter release at ribbon synapses in the retina. Immunol Cell Biol 2000; 78:442-6.